Valuation Mega Lifesciences Thailand S.E.

Stocks

End-of-day quote Thailand S.E. 2026-10-08			5-day change	1st Jan Change
33.25 ^THB	-0.75%		-1.48%	-0.75%

08-24	Mega Lifesciences Public Company Limited, Q2 2026 Earnings Call, Aug 14, 2026
08-13	Mega Lifesciences Public Company Limited Announces Declaration of Interim Dividend for Period from 01 January 2026 to 30 June 2026, Payable on 11 September 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	44,029	40,760	35,093	28,990	29,208	28,990	-	-
Change	-	-7.43%	-13.9%	-17.39%	0.75%	-0.75%	-	-
Enterprise Value (EV) ¹	41,666	38,309	32,456	25,464	25,051	24,373	24,270	23,936
Change	-	-8.06%	-15.28%	-21.54%	-1.62%	-2.71%	-0.42%	-1.37%
P/E	22.6x	18.2x	17.6x	14.4x	15.3x	12.7x	11.7x	10.9x
PBR	5.5x	4.64x	3.77x	2.94x	2.86x	2.64x	2.62x	2.53x
PEG	-	1.2x	-1.6x	16.49x	-2.95x	0.7x	1.26x	1.64x
Capitalization / Revenue	3.08x	2.6x	2.24x	1.89x	2.06x	2.02x	1.87x	1.78x
EV / Revenue	2.91x	2.44x	2.07x	1.66x	1.77x	1.7x	1.57x	1.47x
EV / EBITDA	17.2x	13x	10.2x	6.78x	8.73x	7.7x	6.86x	6.35x
EV / EBIT	18.1x	14.3x	11.2x	7.56x	9.69x	8.69x	7.63x	7.07x
EV / FCF	16.2x	22.6x	19.6x	11.8x	11.9x	10.7x	11.9x	11x
FCF Yield	6.18%	4.42%	5.09%	8.46%	8.41%	9.37%	8.44%	9.11%
Dividend per Share ²	1.06	1.61	1.65	1.6	1.6	1.782	1.909	2.039
Rate of return	2.1%	3.44%	4.1%	4.81%	4.78%	5.36%	5.74%	6.13%
EPS ²	2.23	2.57	2.29	2.31	2.19	2.61	2.851	3.041
Distribution rate	47.5%	62.6%	72.1%	69.3%	73.1%	68.3%	66.9%	67%
Net sales ¹	14,301	15,686	15,681	15,344	14,147	14,330	15,499	16,271
EBITDA ¹	2,426	2,953	3,190	3,756	2,868	3,167	3,537	3,768
EBIT ¹	2,305	2,681	2,904	3,370	2,585	2,803	3,181	3,384
Net income ¹	1,947	2,242	1,993	2,012	1,912	2,243	2,486	2,652
Net Debt ¹	-2,363	-2,451	-2,636	-3,525	-4,156	-4,617	-4,720	-5,053
Reference price ²	50.50	46.75	40.25	33.25	33.50	33.25	33.25	33.25
Nbr of stocks (in thousands)	871,870	871,870	871,870	871,870	871,870	871,870	-	-
Announcement Date	2/23/22	2/25/23	2/22/24	2/24/25	2/24/26	-	-	-

¹THB in Million²THB

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	33.76x	12.26x	24.76x	0.58%	1,060B
JOHNSON & JOHNSON	28.75x	6.35x	18.21x	2.07%	623B
ABBVIE INC.	34.38x	7.99x	16.52x	2.56%	480B
MERCK & CO., INC.	103.88x	5.82x	24.82x	2.39%	352B
ROCHE HOLDING AG	19.43x	4.75x	11.8x	2.78%	345B
NOVARTIS AG	20.28x	5.28x	13.08x	3.01%	274B
ASTRAZENECA PLC	20.79x	4.27x	12.2x	2.08%	249B
AMGEN INC.	26.09x	6.8x	12.11x	2.44%	223B
GILEAD SCIENCES, INC.	-44.42x	6.54x	25.48x	2.24%	182B
Average	26.99x	6.67x	17.66x	2.24%	420.89B
Weighted average by Cap.	32.19x	7.84x	19.08x	1.91%